Massimiliano Petrini

5PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 23, 2026
Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma.

|Jul 02, 2024
In vitro CAR-T cell killing: validation of the potency assay.

Claudia Piccinini, Silvia Carloni, Chiara Arienti

|Mar 30, 2023
The Renewal of Cancer Immunotherapy.

Jenny Bulgarelli, Sara Pignatta, Massimiliano Petrini

|Jul 27, 2022
Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center.

Elena Pancisi, Anna Maria Granato, Emanuela Scarpi

|Jun 02, 2021
Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay.

Silvia Carloni, Claudia Piccinini, Elena Pancisi

Pageof 1

Frequent Collaborators

3 joint publications

Laura Ridolfi

2 joint publications

Elena Pancisi

2 joint publications

Jenny Bulgarelli

2 joint publications

Marcella Tazzari